BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31311071)

  • 1. Quantitative Analysis of Carbonic Anhydrase IX Uncovers Hypoxia-Related Functional Differences in Classical Hodgkin Lymphoma Subtypes.
    Matolay O; Beke L; Gyurkovics A; Francz M; Varjasi G; Rejtő L; Illés Á; Bedekovics J; Méhes G
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.
    Méhes G; Matolay O; Beke L; Czenke M; Jóna Á; Miltényi Z; Illés Á; Bedekovics J
    Histopathology; 2019 Apr; 74(5):699-708. PubMed ID: 30636023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic Anhydrase IX (CAIX) Expressing Hypoxic Micro-environment Hampers CD8+ Immune Cell Infiltrate in Breast Carcinoma.
    Juhász P; Hasulyó D; Bedekovics J; Beke L; Kacsala N; Török M; Méhes G
    Appl Immunohistochem Mol Morphol; 2023 Jan; 31(1):26-32. PubMed ID: 36476599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
    Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
    Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
    Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
    J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D connectomes of reactive and neoplastic CD30 positive lymphoid cells and surrounding cell types.
    Lumer L; Wurzel P; Scharf S; Schäfer H; Ackermann J; Koch I; Hansmann ML
    Acta Histochem; 2021 Jul; 123(5):151750. PubMed ID: 34233254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells.
    Schmidt J; Oppermann E; Blaheta RA; Schreckenbach T; Lunger I; Rieger MA; Bechstein WO; Holzer K; Malkomes P
    Mol Cell Endocrinol; 2021 Sep; 535():111382. PubMed ID: 34216643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
    Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
    J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Carbonic Anhydrase IX is a Dismal Prognostic Marker in Breast Carcinoma in Egyptian Patients.
    Samaka RM; Abd El-Wahed MM; Al Sharaky DR; Shehata MA; Hegazy SE; Aleskandarany MA
    Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):405-13. PubMed ID: 26574633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
    Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
    Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of altered glycosylation of tumor-associated hypoxia biomarker carbonic anhydrase IX.
    Baratova M; Skvarkova L; Bartosova M; Jelenska L; Zatovicova M; Puzderova B; Kajanova I; Csaderova L; Pastorekova S; Svastova E
    Neoplasma; 2023 Jun; 70(3):416-429. PubMed ID: 37498074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.
    Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
    BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.
    Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E
    J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma.
    Kim LH; Eow GI; Peh SC; Poppema S
    Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models.
    Huizing FJ; Hoeben BAW; Franssen GM; Boerman OC; Heskamp S; Bussink J
    Mol Pharm; 2019 Feb; 16(2):701-708. PubMed ID: 30550290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.